Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...

SEER’S JOINT VENTURE PARTNER IN THE KINGDOM OF SAUDI ARABIA HAS BEEN AWARDED LARGE PILOT PROJECT INVOLVING SEVERAL OF THE LARGEST PUBLIC PARKS IN THE KINGDOM AS PART OF THE “GREEN RIYADH” PROJECT BROOMFIELD, CO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Strategic Environmental & Energy Resources, Inc. (SEER) (OTCQB: SENR), a provider of environmental, renewable fuels and industrial waste stream...